US BROKER MOVES: TMO upgraded at UBS; VMC downgraded at Wells Fargo

UPGRADES Figure Technology Solutions (FIGR) Upgraded from Underperform to Neutral at BofA Securities; PT USD 49 Lithium Americas (LAC) Upgraded from Neutral to Overweight at JPMorgan; PT USD 6 Lineage (LINE) Upgraded from Equalweight to Overweight at Morgan Stanley; PT USD 47 Martin Marietta Materials (MLM) Upgraded from Equal Weight to Overweight at Wells Fargo; PT USD 609 Sagimet Biosciences (SGMT) Upgraded from Equalweight to Overweight at Barclays; PT USD 18 Summit Therapeutics (SMMT) Upgraded from Hold to Buy at Jefferies; PT USD 25 Sasol (SSL) Upgraded from Neutral to Buy at BofA Securities Thermo Fisher Scientific (TMO) Upgraded from Neutral to Buy at UBS; PT USD 730 UGI Corp (UGI) Upgraded from Hold to Buy at Jefferies; PT USD 43 DOWNGRADES Amrize (AMRZ) Downgraded from Overweight to Equal Weight at Wells Fargo; PT USD 44 Cheche Group Inc (CCG) Downgraded from Buy to Hold at Maxim Group Eagle Materials (EXP) Downgraded from Overweight to Equal Weight at Wells Fargo; PT USD 196 Patria Investments (PAX) Downgraded from Neutral to Underperform at BofA Securities; PT USD 10 Vulcan Materials (VMC) Downgraded from Equal Weight to Underweight at Wells Fargo; PT USD 254 Westlake (WLK) Downgraded from Outperform to Market Perform at BMO Capital; PT USD 82 INITIATIONS Agilent Technologies (A) Initiated at Neutral at UBS; PT USD 165 AEON Biopharma (AEON) Initiated at Buy at Laidlaw; PT USD 1.80 Akoustis Technologies (AKTS) Initiated at Outperform at Oppenheimer; PT USD 40 Amneal Pharmaceuticals (AMRX) Initiated at Outperform at Leerink; PT USD 23 ANI Pharmaceuticals (ANIP) Initiated at Outperform at Leerink; PT USD 104 Avantor (AVTR) Initiated at Neutral at UBS; PT USD 16 Better Home & Finance (BETR) Initiated at Buy at B. Riley; PT USD 26 Bausch + Lomb (BLCO) Initiated at Outperform at Leerink; PT USD 24 Bruker (BRKR) Initiated at Neutral at UBS; PT USD 65 Caris Life Sciences (CAI) Initiated at Neutral at UBS; PT USD 28 Chime Financial (CHYM) Initiated at Buy at Loop Capital; PT USD 45 Cigna (CI) Initiated at In Line at Evercore ISI; PT USD 290 Collegium Pharmaceutical (COLL) Initiated at Buy at Truist Securities; PT USD 49 Collegium Pharmaceutical (COLL) Initiated at Outperform at Leerink; PT USD 45 DoorDash (DASH) Initiated at Sector Outperform at Scotiabank; PT USD 275 Dave (DAVE) Initiated at Buy at Loop Capital; PT USD 500 Danaher (DHR) Initiated at Buy at UBS; PT USD 250 FuelCell Energy (FCEL) Initiated at Buy at Craig; PT USD 22 Faeth Therapeutics (FTH) Initiated at Buy at TD Cowen Formula One Group (FWONK) Initiated at Buy at Jefferies; PT USD 115 Guardant Health (GH) Initiated at Buy at UBS; PT USD 225 Grail (GRAL) Initiated at Buy at UBS; PT USD 105 Harrow (HROW) Initiated at Outperform at Leerink; PT USD 45 Heartflow (HTFL) Initiated at Neutral at UBS; PT USD 55 Illumina (ILMN) Initiated at Buy at UBS; PT USD 260 Kodiak AI (KDK) Initiated at Buy at Needham; PT USD 8 Lindblad Expeditions (LIND) Initiated at Hold at Jefferies; PT USD 29 Lyft (LYFT) Initiated at Sector Perform at Scotiabank; PT USD 17 MBGL (MBGL) Initiated at In Line at Evercore ISI; PT USD 22 Monarch Casino & Resort (MCRI) Initiated at Buy at Texas Capital Securities; PT USD 147 Mettler-Toledo (MTD) Initiated at Neutral at UBS; PT USD 1,460 Myriad Genetics (MYGN) Initiated at Neutral at UBS; PT USD 3.60 Nautilus Biotechnology (NAUT) Initiated at Outperform at Leerink; PT USD 4 Natera (NTRA) Initiated at Buy at UBS; PT USD 435 Obsidian Therapeutics (OBX) Initiated at Outperform at William Blair Pacific Biosciences (PACB) Initiated at Neutral at UBS; PT USD 1.35 Pacira BioSciences (PCRX) Initiated at Market Perform at Leerink; PT USD 28 Phathom Pharmaceuticals (PHAT) Initiated at Market Perform at Leerink; PT USD 10 Pulse Biosciences (PLSE) Initiated at Buy at Freedom Capital; PT USD 73 Pursuit Attractions and Hospitality (PRSU) Initiated at Buy at Jefferies; PT USD 61 Pasqal Holding (PSQL) Initiated at Buy at Roth; PT USD 20 QIAGEN (QGEN) Initiated at Neutral at UBS; PT USD 47 Repligen (RGEN) Initiated at Buy at UBS; PT USD 225 Red Rock Resorts (RRR) Initiated at Buy at Texas Capital Securities; PT USD 72 Revvity (RVTY) Initiated at Neutral at UBS; PT USD 140 Sagimet Biosciences (SGMT) Initiated at Overweight at Cantor Fitzgerald SoFi Technologies (SOFI) Initiated at Hold at Loop Capital; PT USD 22 Stevanato Group (STVN) Initiated at Neutral at UBS Tempus AI (TEM) Initiated at Neutral at UBS; PT USD 70 Teva Pharmaceutical (TEVA) Initiated at Outperform at Leerink; PT USD 45 TriSalus Life Sciences (TLSI) Initiated at Buy at H.C. Wainwright; PT USD 11 Twist Bioscience (TWST) Initiated at Neutral at UBS; PT USD 144 10x Genomics (TXG) Initiated at Neutral at UBS; PT USD 68 Uber (UBER) Initiated at Sector Outperform at Scotiabank; PT USD 100 Upstart (UPST) Initiated at Hold at Loop Capital; PT USD 34 Viatris (VTRS) Initiated at Outperform at Leerink; PT USD 20 Waters (WAT) Initiated at Buy at UBS; PT USD 490 West Pharmaceutical Services (WST) Initiated at Buy at UBS; PT USD 415 XPeng (XPEV) Initiated at Neutral at UBS